Brought to you by 
Newco NovaMedica gets Russian rights to CoDa's Nexagon wound therapy
03 Jan 2014
Executive Summary
CoDa Therapeutics Inc. (inflammation, wound healing, and tissue repair) has licensed Russian rights for its Nexagon antisense wound therapy to NovaMedica LLC, a new Russian pharmaceutical company.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Topical Delivery
-
Drug Delivery
-
Biotechnology
- Antisense, Oligonucleotides
- Large Molecule
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com